Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.31
+0.03500.82%
Volume:393.85K
Turnover:1.71M
Market Cap:708.66M
PE:5.46
High:4.46
Open:4.31
Low:4.29
Close:4.27
52wk High:5.78
52wk Low:1.01
Shares:164.61M
Float Shares:137.00M
Volume Ratio:2.07
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7890
EPS(LYR):0.1484
ROE:-574.72%
ROA:47.02%
PB:-4.38
PE(LYR):29.01

Loading ...

Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors